Association between Obesity, Race or Ethnicity, and Luminal Subtypes of Breast Cancer
- PMID: 36428500
- PMCID: PMC9687751
- DOI: 10.3390/biomedicines10112931
Association between Obesity, Race or Ethnicity, and Luminal Subtypes of Breast Cancer
Abstract
Luminal breast cancers are the most common genomic subtype of breast cancers where Luminal A cancers have a better prognosis than Luminal B. Exposure to sex steroids and inflammatory status due to obesity are key contributors of Luminal tumor development. In this study, 1928 patients with Luminal A breast cancer and 1610 patients with Luminal B breast cancer were compared based on body mass index (BMI), age, race, menopausal status, and expressed receptors (i.e., estrogen (ER), progesterone (PR), and human epidermal growth factor receptor 2 (HER2)). Patients with Luminal B tumors had a significantly higher mean BMI (Δ = 0.69 kgm−2 [0.17, 1.21], p = 0.010) versus Luminal A. Interestingly, the risks of Luminal B tumors were higher among Black/African American patients versus White and Hispanic patients (p < 0.001 and p = 0.001, respectively). When controlled for each other, Black/African American race (p < 0.001) and increased BMI (p = 0.008) were associated with increased risks of Luminal B carcinoma, while postmenopausal status was associated with a decreased risk (p = 0.028). Increased BMI partially mediated the strong association between Black/African American race and the risk of Luminal B carcinoma. Thus, Black/African American race along with obesity seem to be associated with an increased risk of more aggressive Luminal B breast carcinomas.
Keywords: Luminal A; Luminal B; breast cancer; obesity; race.
Conflict of interest statement
The authors declare no conflict of interest.
Figures

Similar articles
-
Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival.J Surg Res. 2007 Nov;143(1):109-18. doi: 10.1016/j.jss.2007.03.085. J Surg Res. 2007. PMID: 17950079
-
Body mass index and risk of luminal, HER2-overexpressing, and triple negative breast cancer.Breast Cancer Res Treat. 2016 Jun;157(3):545-54. doi: 10.1007/s10549-016-3825-9. Epub 2016 May 24. Breast Cancer Res Treat. 2016. PMID: 27220749 Free PMC article.
-
Distribution of molecular breast cancer subtypes among Algerian women and correlation with clinical and tumor characteristics: a population-based study.Breast Dis. 2015;35(2):95-102. doi: 10.3233/BD-150398. Breast Dis. 2015. PMID: 25736840
-
Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status.BMC Cancer. 2013 May 4;13:225. doi: 10.1186/1471-2407-13-225. BMC Cancer. 2013. PMID: 23642215 Free PMC article.
-
Molecular Profiles of Breast Cancer in Hispanic/Latina.2019 Dec 13. In: Ramirez AG, Trapido EJ, editors. Advancing the Science of Cancer in Latinos [Internet]. Cham (CH): Springer; 2020. Chapter 10. 2019 Dec 13. In: Ramirez AG, Trapido EJ, editors. Advancing the Science of Cancer in Latinos [Internet]. Cham (CH): Springer; 2020. Chapter 10. PMID: 34460196 Free Books & Documents. Review.
Cited by
-
Insights into the molecular and genetic role of obesity in breast cancer pathogenesis.Cancer Biol Ther. 2025 Dec;26(1):2501345. doi: 10.1080/15384047.2025.2501345. Epub 2025 May 12. Cancer Biol Ther. 2025. PMID: 40353441 Free PMC article. Review.
-
Differences in Tumour Aggressiveness Based on Molecular Subtype and Race Measured by [18F]FDG PET Metabolic Metrics in Patients with Invasive Carcinoma of the Breast.Diagnostics (Basel). 2023 Jun 14;13(12):2059. doi: 10.3390/diagnostics13122059. Diagnostics (Basel). 2023. PMID: 37370954 Free PMC article.
-
Obesity as a Risk Factor for Breast Cancer-The Role of miRNA.Int J Mol Sci. 2022 Dec 10;23(24):15683. doi: 10.3390/ijms232415683. Int J Mol Sci. 2022. PMID: 36555323 Free PMC article. Review.
-
Diagnostic implications of lncRNA NORAD in breast cancer.Sci Rep. 2023 Nov 22;13(1):20426. doi: 10.1038/s41598-023-47434-9. Sci Rep. 2023. PMID: 37993524 Free PMC article.
-
Approaches to developing de novo cancer population models to examine questions about cancer and race in bladder, gastric, and endometrial cancer and multiple myeloma: the Cancer Intervention and Surveillance Modeling Network incubator program.J Natl Cancer Inst Monogr. 2023 Nov 8;2023(62):219-230. doi: 10.1093/jncimonographs/lgad021. J Natl Cancer Inst Monogr. 2023. PMID: 37947329 Free PMC article.
References
-
- Makki J., Myint O., Wynn A.A., Samsudin A.T., Daisy Vanitha J. Expression distribution of cancer stem cells, epithelial to mesenchymal transition, and telomerase activity in breast cancer and their association with clinicopathologic characteristics. Clin. Med. Insights: Pathol. 2015;8:CPath-S19615. doi: 10.4137/CPath.S19615. - DOI - PMC - PubMed
-
- Neuhouser M.L., Aragaki A.K., Prentice R.L., Manson J.E., Chlebowski R., Carty C.L., Ochs-Balcom H.M., Thomson C.A., Caan B.J., Tinker L.F. Overweight, obesity, and postmenopausal invasive breast cancer risk: A secondary analysis of the women’s health initiative randomized clinical trials. JAMA Oncol. 2015;1:611–621. doi: 10.1001/jamaoncol.2015.1546. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous